Directory

Peptide catalog

2 peptides with mechanisms, evidence ratings, dosing tables, and provider comparisons.

Weight LossTrending
High evidence

Semaglutide

GLP-1 receptor agonist widely used for weight management and glycemic control. The most clinically studied peptide in this class with multi-year outcome data.

Weight managementView research →
Weight LossTrending
High evidence

Tirzepatide

Dual GIP/GLP-1 agonist showing superior average weight-loss efficacy versus semaglutide in head-to-head and parallel trial programs.

Weight managementView research →